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TGF-b signaling in development and diseaseThe articles assembled in this especial issue of FEBS Letters re-
view current progress and perspectives on various aspects of trans-
forming growth factor b (TGF-b) signaling in development and
disease. A ﬂood of new information emerging at the FASEB Confer-
ence on the TGF-b Superfamily, in August 2011, provided impetus
for this review series. The new work emphasizes key aspects of the
core TGF-b signaling pathway that had long remained obscure. The
TGF-b family was identiﬁed in the early to mid 1980s, and their ba-
sic signal transduction mechanism came to light in the mid 1990s.
Building on those pioneer ﬁndings, many groups set out to explore
the role of this pathway in virtually every major step of embryo-
genesis from stem cell differentiation to body axis formation and
the morphogenesis of tissues and organs. In parallel, an unrelent-
ing effort deﬁned the role of the TGF-b family in the homeostasis
of epithelial and endothelial tissues, hematopoietic and immune
systems, and skeletal and neural organs. Virtually all cell types
were found contain an active TGF-b system regulating cell fate,
proliferation, movement, polarity, adhesion, cytokine production,
modiﬁcation of the microenvironment, terminal differentiation
and cell death. As the prominence of this pathway became increas-
ingly clear, so did the realization that many aspects of the TGF-b
signal transduction process remained inadequately understood.
The present set of review articles covers recent progress in recog-
nizing and elucidating these important gaps of knowledge.
Wylie Vale and Peter Gray describe the versatile role of cripto
co-receptor molecules in controlling the access of TGF-b family
members to signaling receptors. Yoav Henis and his colleagues of-
fer their views on the oligomeric interactions between the receptor
components in the TGF-b and bone morphogenetic protein (BMP)
systems. Thomas Mueller and Joachim Nickel review the determi-
nants of speciﬁcity of BMP receptors. Additional perspectives on
TGF-b receptors are provided by Andrew Hinck and Rik Derynck.
Moving one step further in the pathway, Gopal Sapkota reviews
the regulation of Smad transcription factors by phosphorylation
at the core of the canonical TGF-b signal transduction pathway.
Stuart Newfeld discusses the roles of mono- and poly-ubiquityla-0014-5793/$36.00  2012 Federation of European Biochemical Societies. Published by E
http://dx.doi.org/10.1016/j.febslet.2012.05.030tion of Smad in TGF-b and BMP signaling. Akiko Hata reviews the
unexpected role of Smad proteins in micro-RNAs biosynthesis.
Xuedong Liu discusses the dynamics of TGF-b driven Smad signal-
ing. On a more global scale, Caroline Hill offers perspective on the
spatial regulation of BMP signaling in mammalian cells, and Laurel
Raftery writes on the quantitative imaging of this process in
Drosophila.
Moving on to development and disease, Qiaoran Xi and I review
how Smads interface with the chromatin of differentiation genes in
embryonic stem cells. In their respective articles, Kunxin Luo and
Shirin Bonni discuss the roles of the Smad regulator SnoN in
embryonic development and in post-mitotic neurons, respectively.
Carl Heldin and Aris Moustakas provide an insightful perspective
on the role of TGF-b in epithelial-mesenchymal transitions (EMT)
in development and cancer. Xiao-Jin Wang focuses on Smad4
loss-of-function as a mediator of tumor initiation in head-and-neck
cancer and tumor progression in pancreatic cancer. Perter ten Dijke
focuses on the role of BMP signaling in the cardiovascular system
and its disorders. Harold Dietz and Jeffrey Doyle discuss genetic
disorders that perturb the interaction of TGF-b and the extracellu-
lar matrix, with grave consequences. Alain Mauviel reviews recent
ﬁndings on the crosstalk between the Hedgehog and TGF-b path-
ways and its implications in cancer.
In a separate note, Peter Gray and I celebrate the life and key
contributions of Wylie Vale, who sadly passed away as the present
work was going to press. This issue of FEBS Letters is dedicated in
memory of Wylie Vale.
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